April 12, 2010
Draeger Medical Systems, Inc., US headquarters of Dräger
Medical AG & Co. KG, an international leader in the fields of medical and
safety technology and a worldwide leader in mechanical ventilation
announced today that it has received 510(k) clearance from the FDA to
market the Babylog VN500 in the US. The ventilator is Dräger’s most
advanced product for neonatal ventilation.
New Babylog VN500 for Neonatal Ventilation
The Babylog VN500 ventilator offers the latest technology in mechanical
ventilation specifically designed for the special needs of neonates and infants.
Its versatility and range of operation is well suited for special care nurseries
and pediatric intensive care units.
The Babylog VN500 combines important types of ventilation, such as
conventional ventilation, nasal CPAP, and oxygen therapy in one medical
device. The detachable control panel with 17" touch screen and rotary knob
offers extended possibilities of device control and lung function monitoring.
“Designed with the clinician in mind, the Babylog VN500 combines the latest in
technology coupled with a simplified and easy to use user interface,” said Ed
Coombs, MA RRT and Associate Director of Marketing for Respiratory Care
Systems at Draeger Medical, Inc. “After over two decades of experience with
the Babylog 8000+, our customers have led the development of the next
generation in neonatal ventilation.”
With a company-wide focus to provide exceptional product support services,
Dräger customers will continue to receive support from both our field support
teams and Intensive Care Online Network (ICON).
For more information, please contact
your local Dräger sales representative at 1-800-437-2437.
Dräger Medical AG & Co. KG is the manufacturer of the Babylog VN500. Babylog® is a brand
name of Dräger.
Dräger. Technology for Life®
The Drägerwerk AG & Co. KGaA is an international leader in the fields of medical and safety
technology. Dräger products protect, support and save lives. Founded in 1889, in 2009 Dräger
generated revenues of around EUR 1.9 billion. The Dräger Group is currently present in more
than 190 countries and has about 11,000 employees worldwide.